Fermenta Biotech Limited has submitted a regulatory disclosure to BSE Limited regarding scheduled investor meetings. The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company will participate in one-to-one meetings with investors on July 22, 2026. The meetings will be conducted in physical mode at Mumbai location.
The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during these investor interactions. All relevant materials, including press releases and investor presentations that will be discussed, are already available on the company's website (www.fermentabiotech.com) and on BSE Limited's website (www.bseindia.com).
The disclosure includes a note that changes to the meeting schedule may occur due to exigencies on the part of either the company or the investors.
The communication was digitally signed by Varadvinayak Vijay Khambete, Company Secretary & Head - Legal (Membership No. A33861), on July 17, 2026 at 16:50:13 IST.